In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

David Auth: Riding Heart Technology's Roller Coaster

Executive Summary

Heart Technology is one of the great success stories in medical devices over the past 20 years. But you'd never have predicted that given the company's early experiences. In Vivo interviews the company's founder, David Auth.

You may also be interested in...



Pathway Medical: Pursuing the Hawk

Two years ago, Pathway Medical was nearly out of business. Now it's back, pursuing one of the hottest opportunities in cardiovascular medicine: atherectomy to treat peripheral artery disease.

GGB Awards Extend Entry Deadline To 26 August

Entrants now have an additional week to submit entries for the Global Generics & Biosimilars Awards 2022, which returns to Frankfurt this November.

Everest Refocuses After Trodelvy Twist

A shift in investor sentiment in 2021 hit Everest hard when it was expanding the commercial team for cancer drug Trodelvy. Entering 2022, the sustained downturn in the capital market environment eventually changed the way the Chinese biotech considers launching drugs in the market.

Topics

Related Companies

Related Deals

Latest News
See All
UsernamePublicRestriction

Register

IV003164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel